Health-related quality of life data can be used at the micro, meso and macro levels of decision making.
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Examples include providing information that may assist All surviving patients who had received an allogeneic bone marrow transplant at the Princess Margaret Hosindividual patients and physicians in treatment decision making, treatment teams in planning and developing pital were asked to participate in a health-related quality of life (HQL) study using the Medical Outcomes Surrehabilitation strategies for the post-BMT period, and policy makers in cost-benefit analyses.
vey -Short Form 36 (MOS SF-36), the Satisfaction with Life Domains Scale -Bone Marrow Transplantation
Over the past 5 years there have been many publications directly concerned with the HQL of patients who have (SLDS-BMT) and a current symptoms checklist. The main objective was to compare the health status of BMT undergone BMT (see for example Refs 2-15). The majority of studies were cross-sectional in design, involved small survivors with age-adjusted population norms. Of the 251 patients contacted, 93% returned questionnaires.
numbers of patients and, in general, utilized a battery of questionnaires. Among those used were general measures The median follow-up after BMT was 40 months, ranging from 1-253 months. On average, survivors had some of HQL (such as the Sickness Impact Profile 16 ), measures of mood (eg Profile of Mood States, 17 Symptom Checklistdiminished HQL relative to the health status of the population in general. Time since transplant had a sig-90 18 ) and specific measures (such as the Quality of LifeBone Marrow Transplantation Questionnaire 19 ). The studnificant influence on HQL; those less than 3 years from transplant experienced considerable impairment while ies described the status of post-BMT survivors in terms of psychosocial functioning, 9 cognitive functioning, 20 mood those who had survived beyond this point were indistinguishable from the normal population in most and behaviour, 15, 21, 22 psychosexual functioning, 23, 24 functional ability and employment, 12, 13 and in relation to domains and significantly better in certain psychosocial aspects of health. Many patients still reported symptoms persons in other situations such as those undergoing chemotherapy 14, 23 or renal transplantation.
outcomes of BMT with norms have focused on specific such factors as relationships, health, appearance, leisure time, ability to eat, physical strength, and BMT are domains (eg psychosocial; satisfaction), not on general health status. 9, 28 obtained. Ratings are made on a seven-point scale which has seven 'faces' ranging from extremely happy (broadly up-turned mouth) to extremely unhappy (broadly downturned mouth). The items are summed to give an overall Methods score. Higher scores indicate greater satisfaction. Evidence of internal consistency, sensitivity, and validity have been We surveyed, by mail, all surviving patients who had undergone allogeneic BMT at the PMH. A set of three demonstrated previously. 28, 33 questionnaires was used, including a general health profile questionnaire which had population norms associated with The PMH-SER and demographics: A checklist was used to elicit data on 23 symptoms commonly associated with it. A random subset of 100 patients were asked to complete the questionnaires on a second occasion, 2 weeks later.
BMT (eg fatigue, poor appetite, sore mouth, abdominal pain or discomfort, weight loss/gain, etc). These were rated on a four-point severity scale. The items contained in the Sample checklist were generated from clinical experience and the literature. The survey tool was developed at PMH and has At the time of the PMH postal survey, all 251 surviving allograft recipients (of a total of 525 transplanted patients) not received psychometric testing. One of its main functions was to provide an account of current treatment status were to be included. No selection criteria were imposed. The patients included individuals with CML, AML, ALL, to test for compliance with the prescribed therapy documented in the patient record. aplastic anemia (AA), non-Hodgkin's lymphoma (NHL), multiple myeloma (MM) and a few miscellaneous Demographic, disease and treatment-related information of the following type was also recorded; age, gender, mariconditions (other).
tal status, education, diagnosis, donor type (identical twin, other sibling, other relative or unrelated), time since transMeasures plant (months), presence and grade (four levels, I-IV) of acute GVHD, presence of chronic GVHD, disease status at Three questionnaires were mailed to BMT survivors; the Medical Outcomes Survey -Short Form 36 (MOS SF-BMT in terms of risk (three categories: (1) unspecified, (2) AML and ALL first remission and CML first chronic phase, 36), [29] [30] [31] the Satisfaction with Life Domains Scale -Bone Marrow Transplantation (SLDS-BMT) 28 and the Princess and (3) AML and ALL other than first remission and CML other than first chronic phase), use of BMT-related drugs Margaret Hospital -Symptom Experience Report (PMH-SER).
and numbers of visits to health care facilities or physicians' offices. Some of these data were obtained from the existing PMH BMT database with the patients' permission. The MOS SF-36 Survey: This measure is considered to be 'generic' in that it assesses health concepts that are not age, disease or treatment specific. The developers state that Procedure 'generic health measures assess health-related quality of life outcomes, namely, those known to be most directly affected All surviving patients were mailed a package containing a request for their participation, a consent form, and a set of by disease and treatment' such as functional status and well-being. 32 three questionnaires. A return stamped envelope was included. Patients who did not respond within 2 weeks were The MOS SF-36 self-report questionnaire has eight multi-item concepts containing two to 10 items each for a telephoned and again asked to participate. A randomly selected subset of 100 patients was asked to fill in the total of 36 questions. The concepts for evaluation include physical functioning (PF), role functioning -physical (RP), questionnaires on a second occasion, 2 weeks following completion of the first set. role functioning -emotional (RE), social functioning (SF), bodily pain (BP), mental health (MH), vitality (VT), and general health (GH). Raw scale scores are calculated and Statistical analysis are then transformed to a 0-100 scale. No total score for the MOS SF-36 is generated but each of the eight factors Descriptive statistics were used to summarize the scores for the MOS SF-36 subscales, the SLDS-BMT questionnaire has a summary score. Higher scores indicate better HQL. The questionnaire has been shown to be reliable and valid 32 and the PMH-SER. Comparisons between the MOS SF-36 patient data and normative data were also performed. We and is currently being used in numerous studies and in several languages.
used norms for the ages 18-54 years since these came closest to our patients' ages (19-57 years at the time of the Norms are available for the general US population as a whole and also for seven age groups, males and females survey). Differences in individual HQL scores in various patient combined.
groups defined by demographic and disease-related parameters (eg age at transplant, gender, disease status at the The SLDS-BMT: Eighteen items or domains are captured by this questionnaire. They include aspects of most life time of BMT, donor match, pre-BMT hematological disorder, interval since BMT, GVHD status, etc) were detersituations as well as areas of life that can be affected by cancer and its treatment. Assessments of satisfaction with mined using t-tests and analysis of variance (ANOVA).
1131 Table 1 Characteristics of respondents
Most of the specified parameters are known to influence the outcome of BMT. In addition, multivariate analyses of 
Results

Status at BMT Standard risk 55
Characteristics of the patients between responders and non-responders.
Yes 61
Return of completed questionnaires from the second mailing (test-retest evaluation) was 71%. In determining why the response rate was less than that of the initial mailing, many patients reported that they had thought a second copy of the questionnaires had been sent to them by mistake. By CML). The vast majority had a 6/6 related donor match. Almost two-thirds of recipients experienced chronic GVHD the time this came to light, the defined 2 week interval for test-retest evaluation had been exceeded.
at some time in the post-transplant period.
The following data, elicited using the PMH-SER ques- Table 1 shows details of the patient demographics. There was approximately equal distribution of male and female tionnaire, are not shown in Table 1 but are of interest. At the time of the survey, 173 patients required no further respondents. It should be noted that the gender distributions were different between the patient group (men in the larger immunosuppressive therapy, 11 were receiving GVHD prophylaxis, 32 were being treated for acute GVHD and proportion) and the general population (women in the larger proportion). However, gender was not a contributing factor 15 for chronic GVHD. The majority of patients requiring medications (prednisone and/or cyclosporin and/or to the quality of life of BMT survivors (see below). The youngest person to receive a BMT was 16 years of age; azathioprine) were within the first 3 years after BMT. After 3 years, prednisone was taken by five patients, cyclosporin the oldest was 56 years. At the time of completing the HQL assessment for this study, the age range was from by one, and azathioprine by two patients. During the 4 weeks just prior to reporting their health status, 66.7% had years. The most common diagnosis was CML. Approximately half of the respondents fell into the standard risk made none or one visit to a health care facility or physician's office, 21.6% had made two to four visits and 11.7% category at the time of BMT (ie they were in the first remission of AML or ALL or in the first chronic phase of had made more than four visits.
HQL determinations MOS SF-36:
The question of most interest concerned the health profile of the BMT survivors in relation to the profile of the normal population. When we compared our data to the population means for similar age groups, both genders combined, we found that BMT recipients scored significantly lower than normal individuals on five domains, (all P values were less than 0.05). These domains included physical functioning, role functioning -physical, role functioning -emotional, social functioning, and general health. Figure 1 illustrates the means and standard errors of the eight MOS SF-36 sub-scales for the American general population of males and females (aged 18-54) compared to the BMT survivors. We examined the HQL scores of those recipients who were 3 years or less post-BMT and those who were beyond the norms in 7/8 of the MOS SF-36 domains, P Ͻ 0.05 (see Figure 2 ). Ability to carry out physical activities (RP), vitality (VT) and general health (GH) were all exceedingly diminished. Only in the category of MH (mental health) was there no significant difference. into three categories; those scoring between 5 and 7 were In contrast, the group of 126 recipients (aged grouped as satisfied, those scoring 4 were considered neuyears), who had lived for more than 3 years following BMT tral and those scoring between 1 and 3 were grouped as scored significantly higher in all eight domains of HQL (P not satisfied. Table 2 summarizes the responses. The area values 0.0001-0.0028, t-test) compared to patients within of least satisfaction was 'physical strength' where 65 or 3 years of BMT. As well, the HQL scores of these 126 28% of respondents marked the lowest three categories. recipients were indistinguishable from the population However, 213 (92%) survivors were satisfied with their norms for 5/8 domains and higher than normative HQL BMT; in fact, 65% rated their satisfaction in the highest scores were observed for the domains of social functioning category. In terms of quality of life, 185 (81%) were (SF), mental health (MH) and vitality (VT).
satisfied.
As with the MOS SF-36 scores, there was a difference SLDS-BMT: The seven-point response categories for each between those who were 3 years or less and those who of the questions included in the SLDS-BMT were grouped were more than 3 years post-BMT in overall satisfaction with life domains. Those who were in the latter group were significantly more satisfied; P = 0.0001.
PMH-SER:
Although many respondents experienced a number of low-grade symptoms (scored as mild), this questionnaire identified five symptoms of the 23 listed which were more troublesome. More than 20% of recipients scored themselves as having moderate to severe fatigue, pain, skin dryness, joint stiffness and difficulty sleeping. Ninety-four percent, however, would recommend BMT to patients with the same condition.
Test-retest reliability of questionnaires
The intraclass correlation coefficients for the eight factors coefficient was 0.88. Sample size was 229 unless otherwise indicated. Items are shown in the order in which they appear in the questionnaire.
Effects of demographic, disease and treatment-related
adversely affected satisfaction (P = 0.0001) as did the presence of chronic GVHD (P = 0.0002), age at BMT (P = variables on HQL outcome 0.0188), donor match (P = 0.0003) and interval since transFor discussion purposes, the variables were grouped plant (P = 0.0001). Those who were older at the time of according to pre-BMT features (age, gender, education, BMT, who were closer to the time of their transplant and diagnosis, disease status at BMT, donor match); transplantwho had greater disparity in donor matching scored lower related features (presence of acute or chronic GVHD); and on both the MOS SF-36 and the SLDS-BMT. length of survival (time since transplant). We first reviewed
In multivariate analysis of variance with a single factor, the scores across the eight factors of the MOS SF-36 (raw time since BMT, acute GVHD, chronic GVHD, age at data) according to the specified categories for each variable BMT and donor match each showed significant contriof interest. For example, were scores lower for those who bution (P Ͻ 0.001) to the variation of the eight MOS SFwere older at the time of BMT than those who were 36 subscales. The contribution of education level, gender, younger? Were the scores lower for those closer to the time diagnosis and disease status were not significant (P Ͼ of their transplant? Mean scores were consistently higher 0.05). In the subsequent MANOVA with multiple factors, for those patients with more favorable initial status (pretime since BMT, acute GVHD, chronic GVHD, age at BMT features) and/or more favorable outcome status BMT and donor match were examined simultaneously. (transplant-related features). For instance, those in first Chronic GVHD lost its significance (P = 0.36) in the presremission or first chronic phase of their disease at the time ence of other factors and was eliminated from the final of transplant indicated higher scores across all eight MOS MANOVA. The P values of time since BMT, acute GVHD, SF-36 factors; similarly, those whose acute GVHD was age at BMT and donor match were 0.0001, 0.0094, 0.0577 rated as 0-I or who experienced no chronic GVHD or who and 0.0574, respectively. were less than 30 years of age at the time of BMT or who were more than 3 years since transplant or whose donor was a twin indicated better HQL. Discussion To examine whether certain transplant parameters affected responses to the questionnaires, the variables of interest were analyzed with t-tests or analysis of variance. Table 3 This study is part of an ongoing process to assess HQL in patients undergoing BMT. Almost one-half of all BMT shows the variables and whether or not they adversely affected health status as measured by the MOS SF-36.
recipients transplanted at the Princess Margaret Hospital were alive and all were invited to participate in this survey. Neither gender, education, diagnosis nor disease status at BMT influenced any of the eight domains. The presence of
The main strengths of this study are as follows: no exclusion criteria were imposed on participation, an excelacute GVHD and short interval post-BMT negatively affected all eight factors. Chronic GVHD, age at BMT, a related lent response rate (93%) was achieved and a high rate of consistency of the test-retest data was observed. However, donor mismatch or the use of unrelated donors affected six of the eight factors in a negative way. several limitations should be acknowledged. The HQL assessment was not prospective (ie it was cross-sectional) Similarly, diagnosis, gender, education, and disease status at BMT did not affect satisfaction with life as measin nature; thus, only one assessment at one point in time was undertaken. The influence of time on HQL could only ured by the SLDS-BMT. The presence of acute GVHD be evaluated by dividing the patients into two groups, one for such procedures as BMT, therefore, our sample is not biased by ability to pay. comprising individuals less than or equal to 3 years and the other including those more than 3 years after BMT.
Although group data do not necessarily represent the experiences of a given individual, the BMT recipients in Additionally, the HQL of those who had already succumbed to their disease remains undocumented. We recogthis study, as a group, experienced some (statistically significant) diminished HQL in several areas when comnize that these types of data are also important but can only be obtained through a prospective study. Some of these pared to the general population. These areas included limitations in performing physical activities due to health, problimitations can be addressed and we intend to do so by assessing the HQL of these patients on a regular basis. We lems with work or other daily activities as a result of physical health, interference with normal social activities will then have more than one data point for many of the individuals in the cohort and can test further the hypothesis due to physical or emotional health, problems with work or other daily activities due to physical or emotional health that time since transplant has a major influence on HQL.
One of the practical outcomes of eliciting HQL data is and evaluations of personal health as sub-optimal. In other areas (eg vitality -energy level and fatigue; mental healththat patients contemplating BMT can have some knowledge of the experiences of those who have undergone and suranxiety, depression and psychological well-being; and bodily pain -pain or discomfort) no difference from the norm vived the procedure. This can be of assistance in decision making about transplantation and can provide hope for was detected. We also examined the HQL of the 105 recipients less those faced with the decision. These data also give some direction to the planning and development of supportive than 3 years post-BMT and the 126 recipients who had survived for more than 3 years. In examining the mean and rehabilitative strategies post-BMT and may well be useful in defining clinical practice guidelines and other scores for the eight MOS SF-36 domains for patients closest to the time of BMT, it was evident that these patients health care policies.
Similar studies to this large cross-sectional assessment were, overall, experiencing considerably poorer health status than the normal population (see Figure 2 ). They were of HQL with a group of BMT survivors have, of course, been undertaken by others. The primary contribution made also much more compromised than those beyond the 3 year point. In every domain, mean scores were lower than those by this study pertains to comparisons of the physical, social and emotional functional status of unselected BMT recipifor the general population. They were also all significantly lower than for the BMT recipients more than 3 years postents with the normal population. It addresses the question of whether or not BMT survivors 'return to normal' with transplant. It is clearly evident that, during the interval prior to the 3 year transplant anniversary, many patients have 'normal' status being defined by health-related data from males and females in the general US population. It is recogserious morbidity that interferes with their physical functioning in particular and their experience of good health nized that norms are only useful if the groups are similar and usually no set of norms is absolutely comparable. The in general. In contrast, the MOS SF-36 mean scores of those patients sampling for the normative data used in this study took into account age, gender, employment status/income and race more than 3 years post-BMT had returned to the range of the normative sample. It is of note that the normative values of non-institutionalized individuals in the US. Thus, the sampling appeared to tap a wide spectrum of the general were exceeded in the areas of social functioning (SF), mental health (MH) and vitality (VT). A number of explanorth American population (for example, not only those who could afford health care) and acceptance of these nations for this latter observation are possible. Perhaps those faced with life-threatening diseases change the norms as a 'benchmark' seems reasonable as a first approximation. It should be noted that the Canadian health care 'anchors' against which they judge their personal situation and perceive they are performing much better than they had system does not discriminate against those who cannot pay estimated or expected. Perhaps the comparative 'anchor' is between quality and quantity of life. It behoves health professionals to portray the options in a realistic manner. no longer perfect health and more attention and effort is spent on cultivating psychosocial domains after an existenDescribing HQL outcome in terms of the experiences of those who have undergone the procedure relative to what tial re-evaluation of life. Perhaps to be a long-term survivor, an inner vitality or zest for life, a positive attitude, and one might otherwise, on average, expect to enjoy at one's age is essential for informed decision making. As menstrong social support are all necessary prerequisites.
Although there are conflicting reports about the longtioned above, we are planning to reassess this group of survivors to document further their HQL outcomes (and term HQL outcome of BMT survivors, one study has addressed the issue of 'returning to normal' directly. Andsurvival) with the intention of more fully describing the post-BMT paradigm. At that time, we will also have the rykowski et al 27 asked BMT survivors to indicate whether they had returned to 'normal', were 'almost normal' or opportunity to examine whether measures of HQL taken early in the post-BMT period are predictive of later were 'not normal' across a variety of functional domains. These data are derived from subjective perceptions without outcome. reference to any age-adjusted standards. The domain in which the smallest percentage of respondents reported a return to normal was 'engaging in vigorous physical
